ROBERT KOCH INST has a total of 12 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Germany, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, measurement and machines are COLLABORATIVE GROUP LTD, GUANGZHOU BAIYUNSHAN QIXING PHARMACEUTICAL CO LTD and INVIVIS PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 4 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Machines | |
#4 | Biotechnology | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Lasch Peter | 5 |
#2 | Baldauf Elizabeth | 5 |
#3 | Beekes Michael | 5 |
#4 | Naumann Dieter | 5 |
#5 | Kneipp Janina | 5 |
#6 | Kayser Oliver | 2 |
#7 | Kiderlen Albrecht Ferdinand | 2 |
#8 | Laatsch Hartmut | 2 |
#9 | Reinhardt Kurth | 1 |
#10 | Bo Niklasson | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020127277A1 | A peptide-loaded mhc-i presenting cell and an il-2 with extended half-life for amplifying a cellular cytotoxic immune response | |
DE10339966A1 | Immunogenic constructs for inducing antiviral neutralizing antibodies in humans and animals, comprises selected amino acid sequences from specified locations of envelope proteins | |
DE10020813A1 | Use of N2-substituted benz [f] indazole-4,9-quinones as antiparasitic agents | |
DE10020812A1 | Use of naphthindazole-4,9-quinones as antiparasitics | |
DE19923811C1 | Procedure for the diagnosis of TSE-induced changes in tissues using infrared spectroscopy |